Influence of chimeric monoclonal antibody (cMOv18) molecular size, and route of administration on targeting in ovarian cancer patients

RHM Verheijen; P. Kenemans; M.R. Buist; C.F.M. Molthoff; W.  Hollander; A.C. van Hof; C.W. Burger; J.B Vermorken; J.C. Roos

Influence of chimeric monoclonal antibody (cMOv18) molecular size, and route of administration on targeting in ovarian cancer patients

RHM Verheijen, P. Kenemans, M.R. Buist, C.F.M. Molthoff, W. Hollander, A.C. van Hof, C.W. Burger, J.B Vermorken, J.C. Roos

Research output: Contribution to conference › Abstract › Other research output

Original language	English
Pages	79
Publication status	Published - 1993
Event	International Society of Oncodevelopmental Biology and Medicine - Jerusalem, Israel Duration: 29 Mar 1993 → …

Conference

Conference	International Society of Oncodevelopmental Biology and Medicine
Country/Territory	Israel
City	Jerusalem
Period	29/03/93 → …

Cite this

Verheijen, RHM., Kenemans, P., Buist, M. R., Molthoff, C. F. M., Hollander, W., van Hof, A. C., Burger, C. W., Vermorken, J. B., & Roos, J. C. (1993). Influence of chimeric monoclonal antibody (cMOv18) molecular size, and route of administration on targeting in ovarian cancer patients. 79. Abstract from International Society of Oncodevelopmental Biology and Medicine, Jerusalem, Israel.

@conference{71a623d03624431a87ce2897c7408407,

title = "Influence of chimeric monoclonal antibody (cMOv18) molecular size, and route of administration on targeting in ovarian cancer patients",

author = "RHM Verheijen and P. Kenemans and M.R. Buist and C.F.M. Molthoff and W. Hollander and {van Hof}, A.C. and C.W. Burger and J.B Vermorken and J.C. Roos",

year = "1993",

language = "English",

pages = "79",

note = "International Society of Oncodevelopmental Biology and Medicine ; Conference date: 29-03-1993",

}

Influence of chimeric monoclonal antibody (cMOv18) molecular size, and route of administration on targeting in ovarian cancer patients. / Verheijen, RHM; Kenemans, P.; Buist, M.R. et al.
1993. 79 Abstract from International Society of Oncodevelopmental Biology and Medicine, Jerusalem, Israel.

Research output: Contribution to conference › Abstract › Other research output

TY - CONF

T1 - Influence of chimeric monoclonal antibody (cMOv18) molecular size, and route of administration on targeting in ovarian cancer patients

AU - Verheijen, RHM

AU - Kenemans, P.

AU - Buist, M.R.

AU - Molthoff, C.F.M.

AU - Hollander, W.

AU - van Hof, A.C.

AU - Burger, C.W.

AU - Vermorken, J.B

AU - Roos, J.C.

PY - 1993

Y1 - 1993

M3 - Abstract

SP - 79

T2 - International Society of Oncodevelopmental Biology and Medicine

Y2 - 29 March 1993

ER -